C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/224, 260/265
C07D 403/12 (2006.01) A61K 31/495 (2006.01)
Patent
CA 2025212
A compound selected from the group consisting of those having the formula: (see formula I) and pharmaceutically acceptable acid addition salts thereof, wherein R1 wherein R1 and R4 are independently selected from the group consisting of H and alkyl radicals containing 1 to 4 carbon atoms, R2 and R3 are independently selected from the group consisting of H, O, and alkyl radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R5, R6 and R7 each is located in one of the remaining 5-, 6-, 7- or 8- positions of the quinoxaline nucleus and is selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide desired therapeutic effects, such as alteration in the rate of fluid transport in the gastrointestinal tract, reduction in intraocular pressure, and increase in renal fluid flow.
Allergan Inc.
Gluchowski Charles
Gowling Lafleur Henderson Llp
LandOfFree
(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1658354